Biotech entity
All 1 tracked stories fall under one category: funding. Of the tracked stories, 1 of 1 also mention Oncare, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Sky Impact Capital, all published on February 24, 2026.
Last mentioned: Feb 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: funding. Of the tracked stories, 1 of 1 also mention Oncare, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Sky Impact Capital, all published on February 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Sky Impact Capital. Shared-story counts are live from our verified record — not editorial picks.
Tier-2/3 Rollout
Scaling the clinic model to underserved smaller urban markets across India.
Series A Funding
Oncare announces ₹27 Cr raise led by Sky Impact Capital.
Phase 1 Expansion
Targeted entry into major Indian metro cities beyond the capital.
Oncology startup Oncare has raised ₹27 Crore ($3.2 million) in a Series A funding round led by Sky Impact Capital. The capital will drive the expansion of its specialized clinic network from Delhi NCR into Tier-2 and Tier-3 Indian markets to bridge the gap in cancer care accessibility.
Sky Impact Capital is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
